tradingkey.logo
tradingkey.logo
Search

Heron Therapeutics Inc

HRTX
Add to Watchlist
0.496USD
-0.001-0.24%
Close 07-31 16:00ETQuotes delayed by 15 min
93.57MMarket Cap
LossP/E TTM

HRTX Income Statement

You can find the annual or quarterly income statement of Heron Therapeutics Inc here for insights into the performance and operational efficiency of Heron Therapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
-10.78%34.71M
-0.47%40.59M
16.47%38.21M
3.26%37.20M
12.21%38.90M
19.13%40.78M
4.38%32.81M
13.42%36.02M
17.07%34.67M
14.00%34.23M
18.36%31.43M
14.95%31.76M
26.25%29.61M
45.38%30.03M
14.32%26.56M
23.11%27.63M
17.18%23.46M
0.24%20.66M
16.35%23.23M
-0.99%22.44M
-21.19%20.02M
-41.27%20.61M
-53.16%19.96M
-38.17%22.67M
-19.63%25.40M
21.63%35.08M
115.43%42.62M
112.18%36.66M
173.21%31.60M
186.92%28.84M
130.82%19.79M
103.02%17.28M
218.47%11.57M
686.00%10.05M
--8.57M
--8.51M
--3.63M
--1.28M
----
----
----
----
----
----
----
--0.00
----
----
----
--0.00
----
----
----
--0.00
--0.00
--0.00
--0.00
Revenue
-10.78%34.71M
-0.47%40.59M
16.47%38.21M
3.26%37.20M
12.21%38.90M
19.13%40.78M
4.38%32.81M
13.42%36.02M
17.07%34.67M
14.00%34.23M
18.36%31.43M
14.95%31.76M
26.25%29.61M
45.38%30.03M
14.32%26.56M
23.11%27.63M
17.18%23.46M
0.24%20.66M
16.35%23.23M
-0.99%22.44M
-21.19%20.02M
-41.27%20.61M
-53.16%19.96M
-38.17%22.67M
-19.63%25.40M
21.63%35.08M
115.43%42.62M
112.18%36.66M
173.21%31.60M
186.92%28.84M
130.82%19.79M
103.02%17.28M
218.47%11.57M
686.00%10.05M
--8.57M
--8.51M
--3.63M
--1.28M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
Cost of revenue
25.79%10.64M
8.71%11.12M
25.97%11.91M
-6.28%9.86M
0.15%8.46M
3.47%10.23M
-48.06%9.46M
-47.82%10.52M
-49.90%8.44M
-21.72%9.88M
23.72%18.21M
24.62%20.16M
48.43%16.85M
15.41%12.63M
29.65%14.72M
11.38%16.18M
23.33%11.36M
16.49%10.94M
58.31%11.35M
61.27%14.52M
-13.32%9.21M
-40.83%9.39M
-58.30%7.17M
-33.73%9.01M
-29.01%10.62M
37.18%15.87M
126.97%17.20M
159.76%13.59M
377.56%14.96M
764.87%11.57M
620.84%7.58M
416.39%5.23M
164.17%3.13M
3722.86%1.34M
--1.05M
--1.01M
--1.19M
--35.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
10.43%39.48M
10.77%40.55M
12.71%42.01M
-9.02%38.64M
-9.42%35.75M
-17.65%36.61M
-33.88%37.27M
-42.74%42.47M
-37.03%39.47M
-11.77%44.45M
-17.64%56.36M
-3.84%74.17M
-27.44%62.68M
-32.09%50.38M
-8.67%68.44M
-6.98%77.13M
19.75%86.38M
-9.41%74.19M
-4.35%74.94M
5.73%82.91M
-7.68%72.13M
-13.28%81.90M
1.13%78.35M
-11.33%78.42M
-18.87%78.13M
17.82%94.44M
25.84%77.48M
57.56%88.44M
51.52%96.30M
11.42%80.16M
23.41%61.57M
11.01%56.13M
20.08%63.56M
49.63%71.94M
4.51%49.89M
17.41%50.56M
58.89%52.93M
54.80%48.08M
112.24%47.73M
87.13%43.07M
63.61%33.31M
59.32%31.06M
18.67%22.49M
22.47%23.01M
17.54%20.36M
40.95%19.50M
49.66%18.95M
23.55%18.79M
35.84%17.32M
60.30%13.83M
109.18%12.66M
247.24%15.21M
167.39%12.75M
--8.63M
--6.05M
--4.38M
--4.77M
R&D expenses
4.65%2.38M
17.87%3.75M
-22.28%3.47M
-33.80%2.93M
-50.54%2.28M
-70.98%3.18M
-67.07%4.46M
-74.78%4.43M
-66.65%4.61M
-0.97%10.95M
-46.93%13.56M
-39.06%17.57M
-67.16%13.82M
-61.71%11.06M
-10.67%25.55M
-18.16%28.83M
10.37%42.07M
-35.04%28.88M
-41.86%28.59M
-19.93%35.23M
3.31%38.12M
-7.92%44.45M
41.70%49.18M
6.23%44.00M
-14.14%36.89M
21.02%48.28M
14.09%34.71M
37.36%41.42M
8.62%42.97M
-16.47%39.89M
5.47%30.42M
5.46%30.16M
18.50%39.56M
61.86%47.76M
-4.62%28.84M
4.80%28.60M
107.46%33.38M
81.42%29.50M
112.36%30.24M
68.69%27.29M
10.95%16.09M
16.97%16.26M
-3.33%14.24M
13.28%16.18M
23.22%14.50M
66.44%13.90M
136.99%14.73M
35.59%14.28M
64.86%11.77M
66.31%8.35M
71.43%6.22M
243.36%10.53M
114.48%7.14M
--5.02M
--3.63M
--3.07M
--3.33M
Depreciation, depletion, and amortization
-3.99%529.00K
-7.57%537.00K
5.85%615.00K
-4.68%611.00K
-20.03%551.00K
-18.74%581.00K
-20.08%581.00K
-13.26%641.00K
-4.04%689.00K
-10.85%715.00K
2.97%727.00K
10.13%739.00K
-0.42%718.00K
1.01%802.00K
-6.37%706.00K
-8.58%671.00K
-2.44%721.00K
11.52%794.00K
-1.95%754.00K
-1.48%734.00K
19.00%739.00K
26.24%712.00K
47.60%769.00K
51.42%745.00K
32.98%621.00K
34.29%564.00K
36.39%521.00K
49.09%492.00K
22.57%467.00K
9.09%420.00K
-5.68%382.00K
-19.90%330.00K
15.81%381.00K
25.82%385.00K
33.22%405.00K
64.14%412.00K
38.24%329.00K
29.66%306.00K
73.71%304.00K
46.78%251.00K
56.58%238.00K
24.87%236.00K
16.67%175.00K
36.80%171.00K
33.33%152.00K
96.88%189.00K
70.45%150.00K
58.23%125.00K
62.86%114.00K
92.00%96.00K
66.04%88.00K
83.72%79.00K
37.25%70.00K
--50.00K
--53.00K
--43.00K
--51.00K
Other operating expenses
----
----
---300.00K
---200.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-251.08%-4.76M
-99.09%38.00K
14.92%-3.79M
77.70%-1.44M
165.74%3.15M
140.83%4.17M
82.12%-4.46M
84.80%-6.45M
85.49%-4.80M
49.79%-10.22M
40.48%-24.93M
14.33%-42.40M
47.45%-33.06M
61.98%-20.36M
19.00%-41.88M
18.14%-49.50M
-20.74%-62.92M
12.66%-53.54M
11.43%-51.71M
-8.47%-60.47M
1.18%-52.11M
-3.26%-61.30M
-67.51%-58.38M
-7.67%-55.75M
18.49%-52.73M
-15.68%-59.36M
16.58%-34.85M
-33.27%-51.78M
-24.45%-64.70M
17.09%-51.31M
-1.13%-41.78M
7.61%-38.85M
-5.46%-51.99M
-32.24%-61.89M
13.45%-41.31M
2.35%-42.05M
-47.99%-49.30M
-50.69%-46.80M
-112.24%-47.73M
-87.13%-43.07M
-63.61%-33.31M
-59.32%-31.06M
-18.67%-22.49M
-22.47%-23.01M
-17.54%-20.36M
-40.95%-19.50M
-49.66%-18.95M
-23.55%-18.79M
-35.84%-17.32M
-60.30%-13.83M
-109.18%-12.66M
-247.24%-15.21M
-167.39%-12.75M
---8.63M
---6.05M
---4.38M
---4.77M
Net non-operating interest income (expenses)
Non-operating interest income
----
--2.75M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--433.00K
----
----
----
----
--156.00K
--559.00K
--1.16M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
-50.00%300.00K
1500.83%9.61M
-20.00%400.00K
50.00%600.00K
6.57%600.00K
7.33%600.00K
-18.70%500.00K
-28.95%400.00K
0.00%563.00K
-8.51%559.00K
9.24%615.00K
0.00%563.00K
0.00%563.00K
-74.65%611.00K
181.50%563.00K
40.75%563.00K
-6.17%563.00K
382.00%2.41M
-60.00%200.00K
0.00%400.00K
100.00%600.00K
34.41%500.00K
25.00%500.00K
0.00%400.00K
0.00%300.00K
-34.97%372.00K
-20.00%400.00K
-50.00%400.00K
-62.50%300.00K
--572.00K
--500.00K
--800.00K
--800.00K
----
----
----
----
21.09%1.16M
----
----
----
--958.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gains from sale of securities
-50.00%300.00K
-233.33%-800.00K
-20.00%400.00K
50.00%600.00K
6.57%600.00K
7.33%600.00K
-18.70%500.00K
-28.95%400.00K
0.00%563.00K
-8.51%559.00K
9.24%615.00K
0.00%563.00K
0.00%563.00K
--611.00K
181.50%563.00K
40.75%563.00K
-6.17%563.00K
----
-60.00%200.00K
0.00%400.00K
100.00%600.00K
34.41%500.00K
25.00%500.00K
0.00%400.00K
0.00%300.00K
-34.97%372.00K
-20.00%400.00K
-50.00%400.00K
-62.50%300.00K
--572.00K
--500.00K
--800.00K
--800.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
----
--0.00
-869.92%-11.64M
-110.53%-200.00K
----
----
---1.20M
--1.90M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
- Gains from disposal of fixed assets
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
Other non-operating income (expenses)
-544.70%-3.35M
1014.71%4.67M
-354.69%-2.06M
84.14%-744.00K
-131.68%-519.00K
-1.19%-510.00K
1125.32%810.00K
-1463.37%-4.69M
455.25%1.64M
-203.70%-504.00K
-203.85%-79.00K
105.01%344.00K
130.57%295.00K
-44.01%486.00K
96.29%-26.00K
-1156.59%-6.86M
-93.00%-965.00K
188.12%868.00K
---700.00K
---546.00K
---500.00K
-168.31%-985.00K
----
----
----
-17.83%1.44M
-63.37%1.26M
750.82%1.56M
713.82%1.69M
4718.42%1.75M
--3.43M
--183.00K
---275.00K
---38.00K
----
----
----
----
-328.18%-775.00K
----
----
184.44%776.00K
---181.00K
57.73%-93.00K
----
---919.00K
----
---220.00K
----
----
----
----
----
----
----
----
----
Income before tax
-407.82%-8.11M
-180.64%-2.95M
-260.87%-17.50M
74.22%-2.38M
183.39%2.63M
134.16%3.66M
80.61%-4.85M
78.04%-9.23M
90.36%-3.16M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
63.64%-19.87M
20.04%-41.91M
7.63%-56.36M
-21.43%-63.89M
12.26%-54.65M
10.00%-52.41M
-10.55%-61.02M
-2.01%-52.61M
-7.53%-62.28M
-73.32%-58.23M
-9.89%-55.19M
18.14%-51.58M
-16.87%-57.92M
12.39%-33.59M
-29.87%-50.22M
-20.56%-63.01M
20.69%-49.56M
8.41%-38.35M
9.65%-38.67M
-3.85%-52.27M
-30.29%-62.49M
13.69%-41.87M
0.99%-42.80M
-50.48%-50.33M
-53.52%-47.96M
-113.96%-48.51M
-87.07%-43.23M
-62.59%-33.45M
-51.48%-31.24M
-18.12%-22.67M
-21.55%-23.11M
-17.29%-20.57M
-46.86%-20.62M
-49.10%-19.19M
-23.34%-19.01M
-35.40%-17.54M
-59.13%-14.04M
-106.00%-12.87M
-240.54%-15.41M
-168.18%-12.95M
---8.82M
---6.25M
---4.53M
---4.83M
Income tax
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
--0.00
----
----
--0.00
----
----
----
----
--0.00
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
-407.82%-8.11M
-180.64%-2.95M
-260.87%-17.50M
74.22%-2.38M
183.39%2.63M
134.16%3.66M
80.61%-4.85M
78.04%-9.23M
90.36%-3.16M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
63.64%-19.87M
20.04%-41.91M
7.63%-56.36M
-21.43%-63.89M
12.26%-54.65M
10.00%-52.41M
-10.55%-61.02M
-2.01%-52.61M
-7.53%-62.28M
-73.32%-58.23M
-9.89%-55.19M
18.14%-51.58M
-16.87%-57.92M
12.39%-33.59M
-29.87%-50.22M
-20.56%-63.01M
20.69%-49.56M
8.41%-38.35M
9.65%-38.67M
-3.85%-52.27M
-30.29%-62.49M
13.69%-41.87M
0.99%-42.80M
-50.48%-50.33M
-53.52%-47.96M
-113.96%-48.51M
-87.07%-43.23M
-62.59%-33.45M
-51.48%-31.24M
-18.12%-22.67M
-21.55%-23.11M
-17.29%-20.57M
-46.86%-20.62M
-49.10%-19.19M
-23.34%-19.01M
-35.40%-17.54M
-59.13%-14.04M
-106.00%-12.87M
-240.54%-15.41M
-168.18%-12.95M
---8.82M
---6.25M
---4.53M
---4.83M
Net income from continuous operations
-407.82%-8.11M
-180.64%-2.95M
-260.87%-17.50M
74.22%-2.38M
183.39%2.63M
134.16%3.66M
80.61%-4.85M
78.04%-9.23M
90.36%-3.16M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
63.64%-19.87M
20.04%-41.91M
7.63%-56.36M
-21.43%-63.89M
12.26%-54.65M
10.00%-52.41M
-10.55%-61.02M
-2.01%-52.61M
-7.53%-62.28M
-73.32%-58.23M
-9.89%-55.19M
18.14%-51.58M
-16.87%-57.92M
12.39%-33.59M
-29.87%-50.22M
-20.56%-63.01M
20.69%-49.56M
8.41%-38.35M
9.65%-38.67M
-3.85%-52.27M
-30.29%-62.49M
13.69%-41.87M
0.99%-42.80M
-50.48%-50.33M
-53.52%-47.96M
-113.96%-48.51M
-87.07%-43.23M
-62.59%-33.45M
-51.48%-31.24M
-18.12%-22.67M
-21.55%-23.11M
-17.29%-20.57M
-46.86%-20.62M
-49.10%-19.19M
-23.34%-19.01M
-35.40%-17.54M
-59.13%-14.04M
-106.00%-12.87M
-240.54%-15.41M
-168.18%-12.95M
---8.82M
---6.25M
---4.53M
---4.83M
Net income from discontinued operations
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
--1.09M
--128.00K
---43.00K
---91.00K
Non-recurring net income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-407.82%-8.11M
-180.64%-2.95M
-260.87%-17.50M
74.22%-2.38M
183.39%2.63M
134.16%3.66M
80.61%-4.85M
78.04%-9.23M
90.36%-3.16M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
63.64%-19.87M
20.04%-41.91M
7.63%-56.36M
-21.43%-63.89M
12.26%-54.65M
10.00%-52.41M
-10.55%-61.02M
-2.01%-52.61M
-7.53%-62.28M
-73.32%-58.23M
-9.89%-55.19M
18.14%-51.58M
-16.87%-57.92M
12.39%-33.59M
-29.87%-50.22M
-20.56%-63.01M
20.69%-49.56M
8.41%-38.35M
9.65%-38.67M
-3.85%-52.27M
-30.29%-62.49M
13.69%-41.87M
0.99%-42.80M
-50.48%-50.33M
-53.52%-47.96M
-113.96%-48.51M
-87.07%-43.23M
-62.59%-33.45M
-51.48%-31.24M
-18.12%-22.67M
-21.55%-23.11M
-17.29%-20.57M
-46.86%-20.62M
-49.10%-19.19M
-23.34%-19.01M
-35.40%-17.54M
-81.50%-14.04M
-110.31%-12.87M
-237.34%-15.41M
-163.22%-12.95M
---7.74M
---6.12M
---4.57M
---4.92M
Net income attributable to common shareholders
-407.82%-8.11M
-180.64%-2.95M
-260.87%-17.50M
74.22%-2.38M
183.39%2.63M
134.16%3.66M
80.61%-4.85M
78.04%-9.23M
90.36%-3.16M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
63.64%-19.87M
20.04%-41.91M
7.63%-56.36M
-21.43%-63.89M
12.26%-54.65M
10.00%-52.41M
-10.55%-61.02M
-2.01%-52.61M
-7.53%-62.28M
-73.32%-58.23M
-9.89%-55.19M
18.14%-51.58M
-16.87%-57.92M
12.39%-33.59M
-29.87%-50.22M
-20.56%-63.01M
20.69%-49.56M
8.41%-38.35M
9.65%-38.67M
-3.85%-52.27M
-30.29%-62.49M
13.69%-41.87M
0.99%-42.80M
-50.48%-50.33M
-53.52%-47.96M
-113.96%-48.51M
-87.07%-43.23M
-62.59%-33.45M
-51.48%-31.24M
-18.12%-22.67M
-21.55%-23.11M
-17.29%-20.57M
-46.86%-20.62M
-49.10%-19.19M
-23.34%-19.01M
-35.40%-17.54M
-81.50%-14.04M
-110.31%-12.87M
-237.34%-15.41M
-163.22%-12.95M
---7.74M
---6.12M
---4.57M
---4.92M
Basic earnings per share
-349.10%-0.04
-165.59%-0.02
-223.77%-0.10
74.50%-0.02
182.15%0.02
133.75%0.02
81.61%-0.03
82.74%-0.06
92.39%-0.02
57.50%-0.07
54.01%-0.17
36.17%-0.35
56.08%-0.27
68.87%-0.17
27.07%-0.38
11.19%-0.55
-8.66%-0.63
21.66%-0.54
19.76%-0.51
-1.90%-0.62
-0.91%-0.58
-5.30%-0.68
-52.51%-0.64
3.68%-0.61
29.00%-0.57
-2.39%-0.65
14.72%-0.42
-17.47%-0.63
0.49%-0.80
41.52%-0.63
36.23%-0.49
32.45%-0.54
18.93%-0.81
11.16%-1.08
37.69%-0.77
31.81%-0.80
-7.89%-1.00
-40.88%-1.22
-95.69%-1.24
-56.71%-1.17
-31.91%-0.92
-22.85%-0.87
4.23%-0.63
4.96%-0.74
5.48%-0.70
5.89%-0.71
20.96%-0.66
22.31%-0.78
12.80%-0.74
-46.38%-0.75
-87.73%-0.84
-120.85%-1.01
-72.59%-0.85
---0.51
---0.45
---0.46
---0.49
Diluted earnings per share
-419.66%-0.04
-165.59%-0.02
-223.77%-0.10
74.50%-0.02
164.02%0.01
133.75%0.02
81.61%-0.03
82.74%-0.06
92.39%-0.02
57.50%-0.07
54.01%-0.17
36.17%-0.35
56.08%-0.27
68.87%-0.17
27.07%-0.38
11.19%-0.55
-8.66%-0.63
21.66%-0.54
19.76%-0.51
-1.90%-0.62
-0.91%-0.58
-5.30%-0.68
-52.51%-0.64
3.68%-0.61
29.00%-0.57
-2.39%-0.65
14.72%-0.42
-17.47%-0.63
0.49%-0.80
41.52%-0.63
36.23%-0.49
32.45%-0.54
18.93%-0.81
11.16%-1.08
37.69%-0.77
31.81%-0.80
-7.89%-1.00
-40.88%-1.22
-95.69%-1.24
-56.71%-1.17
-31.91%-0.92
-22.85%-0.87
4.23%-0.63
4.96%-0.74
5.48%-0.70
5.89%-0.71
20.96%-0.66
22.31%-0.78
12.80%-0.74
-46.38%-0.75
-87.73%-0.84
-120.85%-1.01
-72.59%-0.85
---0.51
---0.45
---0.46
---0.49
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Heron Therapeutics Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing HRTX stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Heron Therapeutics Inc's revenue at year end?

Heron Therapeutics Inc reported 154.90M in revenue for fiscal year 2025, up from 144.28M in the previous year.

How much revenue did Heron Therapeutics Inc report in the most recent quarter?

Heron Therapeutics Inc reported 34.71M in revenue for the most recent quarter, an increase of -10.78% year over year.

What was Heron Therapeutics Inc's net income for the year?

Heron Therapeutics Inc posted -20.20M in net income for fiscal year 2025.

How much net income did Heron Therapeutics Inc post in the last quarter?

Heron Therapeutics Inc reported -8.11M in net income for the latest quarter。

What was Heron Therapeutics Inc's annual operating profit?

Heron Therapeutics Inc's operating income was -2.54M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.